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Aiming to identify lncRNAs involved in activating NF-κB signaling elicited by inflammation, Liu et al. profiled lncRNA expression in human breast cancer cells after treatment with inflammatory cytokines TGF-α (tumor necrosis factor α), IL-1β (interleukin 1β) and NF-κB activator LPS (lipopolysaccharide). The authors focused on the lncRNAs that could up-or down-regulate by all the above stimuli by more than 10-fold. One such lncRNA, aptly named NF-κB Interacting LncRNA (NKILA), stood out by virtue of up-regulating about 12-fold.
Furthermore, a constitutively active IkappaB kinase-2 (CA-IΚΚ2), one member of NF-κB family, induced NF-κB activation and up-regulated NKILA expression in cells, which could be completely inhibited by Sc-3060 and JSH-23, two inhibitors for NF-κB nuclear translocation. These findings suggest that NKILA may represent an essential node in the implement of pro-inflammation functions by NF-κB.
The authors then asked the mechanisms by which NKILA interfere NF-κB activation. It's now accepted that abnormal constitutively activation of NF-κB signaling pathway has a crucial role in inflammation, and further to promote cancer initiation and progression (7, 8) . NF-κB inhibition is expected to be beneficial in the treatment of breast cancer (9). Liu et al. Recent publications have shown lncRNAs regulate important aspects of immunity such as production of inflammatory mediators, differentiation, and cell migration through RNA-protein interactions or basepair complement with RNA and DNA in inflammationrelated diseases (11) . Despite the rapid development with the technologies associated with lncRNAs such as RNA-pull down, capture hybridization analysis of RNA targets (CHART) (12) and massive parallel sequencing, it is still challenging to identify functionally relevant lncRNAs due to obstacles including poor evolutionary sequence conservation, lack of animal model conservation across species and complex function of Yan et al lncRNAs themselves involved. Regardless of these limitation, given the comprehensive and profound role of inflammation in pathology and carcinogenesis, it is reasonable to envisage that there are many additional inflammation-related lncRNAs to be discovered and further studies are required to explore the actual regulation mechanisms of lncRNAs, which will benefit to discover the new target for cancer therapy and accelerate the process of "bench to bed".
